Target intelligence / Profile preview

White spot syndrome virus (WSSV)

Target
WSSV
Molecular classification
Viral protein, Viral genome
01

Overview

White spot syndrome virus (WSSV) is a large, double-stranded DNA virus and the sole member of the genus Whispovirus within the family Nimaviridae (ICTV, 2023). It is the causative agent of White Spot Syndrome (WSS), a highly contagious and lethal disease affecting a wide range of crustacean species, particularly penaeid shrimp (WOAH, 2021). The virus targets various tissues of ectodermal and mesodermal origin, including the gills, lymphoid organ, and cuticular epithelium, leading to rapid mortality within 3 to 10 days of infection (PubMed: 15650231). WSSV's genome encodes approximately 180 open reading frames, with major structural proteins like VP28 and VP26 playing critical roles in viral attachment and entry into host cells (UniProt: Q9J8B0). Therapeutic strategies currently under investigation include RNA interference (RNAi) targeting essential viral genes, the use of recombinant viral proteins as oral vaccines, and the application of immunostimulants to bolster the shrimp's innate immune response (PubMed: 22403537). Despite extensive research, there are currently no widely available commercial drugs or vaccines, making WSSV a significant economic threat to the global aquaculture industry (FAO, 2022).

Other names
WhispovirusWhite spot baculovirus (WSBV)Systemic ectodermal and mesodermal baculovirus (SEMBV)Shrimp explosive epidemic disease (SEED)
02

Mechanism of action

Inhibition of viral replication via RNA interference, competitive inhibition of viral entry, and stimulation of innate immune responses.

03

Biological functions

Viral attachmentViral entryViral replicationHost cell lysisImmune evasion
04

Disease associations

White spot syndromeInfection
05

Safety considerations

Environmental toxicity of treatmentsDevelopment of viral resistanceSpecies-specific efficacyDelivery challenges in aquatic environments
06

Interacting drugs

VP28-targeting dsRNA

3 more in the full profile.

07

Biomarkers

WSSV DNA (detected by PCR)VP28 protein expressionWhite spots on the carapace

Beyond the preview

Go deeper on White spot syndrome virus (WSSV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on White spot syndrome virus (WSSV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call